| |
| |
| |
| |
| |
| | | | |
|
PR:P42772 | cyclin-dependent kinase 4 inhibitor B (human) | | | | | |
| | | | | |
|
PR:P42772-1 | cyclin-dependent kinase 4 inhibitor B isoform 1 (human) | | | | | |
| | | | | |
|
PR:P42772-2 | cyclin-dependent kinase 4 inhibitor B isoform h2 (human) | | | | | |
| | | | | |
|
PR:000000270 | cyclin-dependent kinase 4 inhibitor B sequence variant A50V (human) | | | | | |
| | | | | |
|
PR:000000269 | cyclin-dependent kinase 4 inhibitor B sequence variant G47E (human) | | | | | |
| |
| |
| | | | |
|
PR:P42772 | cyclin-dependent kinase 4 inhibitor B (human) | | | | | |
| | | | | |
|
PR:P42772-1 | cyclin-dependent kinase 4 inhibitor B isoform 1 (human) | | | | | |
| | | | | |
|
PR:P42772-2 | cyclin-dependent kinase 4 inhibitor B isoform h2 (human) | | | | | |
| | | | | |
|
PR:000000270 | cyclin-dependent kinase 4 inhibitor B sequence variant A50V (human) | | | | | |
| | | | | |
|
PR:000000269 | cyclin-dependent kinase 4 inhibitor B sequence variant G47E (human) | | | | | |